Evidence map›Paper›PMID 37325275›Full record

ArticleSkin appendage disorders2023

COVID-19 Infection in Hidradenitis Suppurativa Patients: A Retrospective Study.

Devea R De, Jonathan W Rick, Terri Shih, Jennifer L Hsiao, Iltefat Hamzavi, Vivian Y Shi

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Skin appendage disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Devea R DeJacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
Jonathan W RickUniversity of Arkansas for Medical Sciences, Department of Dermatology, Little Rock, Arkansas, USA.
Terri ShihDavid Geffen School of Medicine, University of California, Los Angeles, California, USA.
Jennifer L HsiaoDepartment of Dermatology, University of Southern California, Los Angeles, California, USA.
Iltefat HamzaviDepartment of Dermatology, Henry Ford Health System, Detroit, Michigan, USA.
Vivian Y ShiUniversity of Arkansas for Medical Sciences, Department of Dermatology, Little Rock, Arkansas, USA.
University of Arkansas for Medical Sciences · USHenry Ford Health System · USJacobs (United States) · USUniversity of California, Los Angeles · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hidradenitis suppurativa (HS) is associated with comorbidities that are risk factors for severe COVID-19 infection. We evaluated demographics and COVID-19 outcomes in HS patients. Methods: HS patients with COVID-19 (HS+/COVID+) and a randomized age-, race-, and sex-matched control population of patients without HS with COVID-19 (HS-/COVID+) were selected through a retrospective chart review. Data were collected on demographics, medications, comorbidities, vaccination status, and COVID-19 treatment/outcomes. Fisher's exact test was used to analyze the relationship between risk factors and COVID-19 outcomes. A Results: There were 58 HS+/COVID+ patients, primarily African American (83%, Conclusion: Our findings support the growing evidence that having HS itself may not be a risk factor for severe COVID-19 outcomes.

Indexed as

COVID-19Hidradenitis suppurativaOutcomesSkin of colorVaccination

Identifiers

PMID37325275
PMCPMC10025363
OpenAlexW4323655773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.